- Global Pharma News & Resources

$6.4 Billion Worldwide In Vivo CRO Industry to 2027 - Increasing Usage of Outsourcing Services Due to Economic Benefits is Driving Growth -

DUBLIN--(BUSINESS WIRE)--The "In Vivo CRO Market Research Report by Type, GLP Type, Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global In Vivo CRO Market size was estimated at USD 3,749.42 million in 2021, USD 4,089.79 million in 2022, and is projected to grow at a CAGR of 9.33% to reach USD 6,404.28 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In Vivo CRO Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global In Vivo CRO Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global In Vivo CRO Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In Vivo CRO Market?

4. What is the competitive strategic window for opportunities in the Global In Vivo CRO Market?

5. What are the technology trends and regulatory frameworks in the Global In Vivo CRO Market?

6. What is the market share of the leading vendors in the Global In Vivo CRO Market?

7. What modes and strategic moves are considered suitable for entering the Global In Vivo CRO Market?

Market Dynamics


  • Increasing usage of outsourcing services due to economic benefits
  • Growing investments in the pharmaceutical research by public and private sectors
  • Rising focus on the development of biosimilar medicines and drugs


  • High cost associated with the clinical trial processes


  • Globalization of clinical trial processes
  • Competitive landscape in the pharmaceutical sector with patent applications


  • Issues related to quality control in in vivo CROs

Companies Mentioned

  • American Preclinical Services, LLC
  • Champion Oncology, Inc.
  • Charles River Laboratories
  • Covance, Inc.
  • Crown Bioscience, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • ICON Plc
  • Labcorp Drug Development
  • Living Tumor Laboratory
  • MI Bioresearch, Inc.
  • Parexel International Corporation
  • PPD Inc.
  • Syneos Health
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • Theorem Clinical Research Inc.
  • WuXi AppTec, Inc.
  • Xentech

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 07-Nov-2022